Steven B. Singer

Director of Litigation

Steven B.

Tel: 914.437.8576

Fax: 888.631.3611

10 Bank Street
8th Floor
White Plains, NY 10606

Steven B. Singer

Director of Litigation

Steven B. Singer is the Director of Litigation at Saxena White P.A., where he oversees the Firm’s securities litigation practice. Prior to joining the Firm, Mr. Singer was employed for more than 20 years at Bernstein Litowitz Berger & Grossmann LLP, a well-known plaintiffs’ firm, where he served as a senior partner and member of the firm’s management committee.

During his career Mr. Singer has been the lead partner responsible for prosecuting many of the most significant and high-profile securities cases in the country, which collectively have recovered billions of dollars for investors. He led the litigation against Bank of America relating to its acquisition of Merrill Lynch, which resulted in a landmark settlement shortly before trial ($2.43 billion), one of the largest recoveries in history. Mr. Singer’s work on that case was the subject of extensive media coverage, including numerous articles published in The New York Times. He also has substantial trial experience and was one of the lead trial lawyers on the WorldCom Securities Litigation ($6 billion settlement) after a four-week jury trial.

In addition, Mr. Singer has been lead counsel in numerous other actions that have resulted in substantial settlements, including cases involving Citigroup Inc. ($730 million, representing the second largest recovery in a case brought on behalf of bond purchasers), Lucent Technologies ($675 million), Mills Corp. ($203 million), WellCare Health Plans ($200 million), Satyam Computer Services ($150 million), Biovail Corp. ($138 million), Bank of New York Mellon ($180 million), JP Morgan Chase ($150 million), and one of the largest settlements in 2018, Wilmington Trust ($210 million).

At Saxena White, Mr. Singer serves as lead counsel in many highly significant securities matters, including In re Wells Fargo & Company Shareholder Derivative Litigation, and securities class actions involving Novo Nordisk, Universal Health Services, and DaVita Inc.

Mr. Singer has been consistently recognized by industry observers for his legal excellence and achievements. He has been selected by Lawdragon magazine as one of the “500 Leading Lawyers in America,” by Benchmark Plaintiff as a “Litigation Star”, and by the Legal 500 US Guide as one of the “Leading Lawyers” in securities litigation -- one of only seven plaintiffs’ attorneys so recognized.

Mr. Singer graduated cum laude from Duke University in 1988, and from Northwestern University School of Law in 1991. He is a member of the New York State Bar, as well as the United States Court of Appeals for the Second Circuit, and the United States District Courts for the Southern and Eastern Districts of New York.

Education
  • Northwestern University School of Law, JD
  • Duke University, BA
Bar Admissions
  • New York
  • U.S. Court of Appeals for the Second Circuit
  • U.S. District Court for the Southern District of New York
  • U.S. District Court for the Eastern District of New York
Practice Areas
  • Securities Class Actions
  • Case Analysis